A Randomized Controlled Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro Alone to Further Improve Glycemic Control in Type 1 Diabetes Mellitus Subjects With Good Glycemic Control
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Diasome Pharmaceuticals
- 30 Jan 2018 Planned End Date changed from 1 Dec 2017 to 18 Feb 2018.
- 30 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 20 Apr 2017 Status changed from not yet recruiting to recruiting.